Friday, 8 February 2019

UniQure gene therapy shows rise in blood-clotting protein levels

Drug developer UniQure NV said on Friday its gene therapy to treat hemophilia B increased the levels of a protein that helps in blood clotting after 12 weeks in a small study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)